Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock

European Journal of Pharmacology

Volumn 573, Issue 1-3, 2007, Pages 111-115

  Borowicz, Kinga K ^a   Morawska, Marta ^a   Furmanek Karwowska, Kamila ^a   Luszczki, Jarogniew J ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Antiepileptic drugs; Cholecalciferol; Electroshock maximal; Pharmacokinetic interaction; Vitamin D3

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; COLECALCIFEROL; DEVICAP; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CHIMNEY TEST; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; ELECTRIC SHOCK; LONG TERM MEMORY; MALE; MAXIMUM ALLOWABLE CONCENTRATION; MOTOR COORDINATION; MOUSE; NEUROLOGIC EXAMINATION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ANIMALS; ANTICONVULSANTS; AVOIDANCE LEARNING; CARBAMAZEPINE; CHOLECALCIFEROL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTROSHOCK; INJECTIONS, INTRAPERITONEAL; MALE; MENTAL RECALL; MICE; MOTOR ACTIVITY; PHENOBARBITAL; PHENYTOIN; SEIZURES; VALPROIC ACID; VITAMINS;

EID: 34648849220     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.07.002     Document Type: Article

References (18)

1. Boissier J.R., Tardy J., and Diverres J.C. Une nouvelle methode simple pour explorer l'action tranquilisante: le test de la cheminee. Med. Exp. (Basel) 3 (1960) 81-84
2. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., and Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 21 (2001) 98-108
3. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., and Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13 (2002) 100-105
4. Gupta M.M., and Grover D.N. Hypocalcemia and convulsions. Postgrad. Med. J. 53 (1977) 330-333
5. 3 in the rat. J. Biol. Chem. 251 (1976) 1020-1021
6. Kulak W., Sobaniec W., Wojtal K., and Czuczwar S.J. Calcium modulation in epilepsy. Pol. J. Pharmacol. 56 (2004) 29-41
7. Lansdowne A.T., and Provost S.C. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology 135 (1998) 319-323
8. Litchfield J.T., and Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96 (1949) 99-113
9. Kalueff A.V., Eremin K.O., and Tuohimaa P. Mechanisms of neuroprotective action of vitamin D3. Biochemistry (Moscow) 69 (2004) 738-741
10. Kalueff A.V., Minasyan A., and Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res. Bull. 67 (2005) 156-160
11. Kalueff A.V., Minasyan A., Keisala T., Kuuslahti M., Miettinen S., and Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci. Lett. 394 (2006) 69-73
12. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?. Schizophr. Res. 40 (1999) 173-177
13. McGrath J. Does 'imprinting' with low prenatal vitamin D contributes to the risk of various adult disorders?. Med. Hypotheses 56 (2001) 367-371
14. Mintzer S., Boppana P., Toguri J., and DeSantis A. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine. Epilepsia 47 (2006) 510-515
15. Nguyen T.M., Lieberherr M., Fritsch J., Guillozo H., Alvarez M.L., Fitouri Z., Jehan F., and Garabedian M. The rapid effects of 1,25-dihydroxyvitamin D3 require the Vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing Vitamin D receptor mutations. J. Biol. Chem. 279 (2004) 7591-7597
16. Norman A.W., Henry H.L., Bishop J.E., Song X., Bula C., and Okamura A.W. Different shapes of the steroid hormone 1α,25(OH)2-vitamin D3 act as agonists for two different receptors in the vitamin D endocrine system to mediate genomic and rapid responses. Steroids 66 (2001) 147-158
17. Siegel A., Malkowitz L., Moscowitz M.J., and Christakos S. Administration of 1,25-hydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res. 298 (1984) 125-129
18. Venault P., Chapouthier G., De Carvalho L.P., Simiand J., Morre M., Dodd R.H., and Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature 321 (1986) 864-866